APA (7th ed.) Citation

Leanza, C., Mascellino, M. T., Volpicelli, L., Covino, S., Falletta, A., Cancelli, F., . . . Oliva, A. (2024, July). Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: A single-center preliminary experience. Frontiers in Microbiology.

Chicago Style (17th ed.) Citation

Leanza, Cristiana, et al. "Real-world Use of Imipenem/cilastatin/relebactam for the Treatment of KPC-producing Klebsiella Pneumoniae Complex and Difficult-to-treat Resistance (DTR) Pseudomonas Aeruginosa Infections: A Single-center Preliminary Experience." Frontiers in Microbiology Jul. 2024.

MLA (9th ed.) Citation

Leanza, Cristiana, et al. "Real-world Use of Imipenem/cilastatin/relebactam for the Treatment of KPC-producing Klebsiella Pneumoniae Complex and Difficult-to-treat Resistance (DTR) Pseudomonas Aeruginosa Infections: A Single-center Preliminary Experience." Frontiers in Microbiology, Jul. 2024.